In his first interview since his wife's death, Caden Hutchins tells TODAY.com about her early symptoms and positive attitude ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is currently ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

The company is on track to complete the interim data analysis before the end of Q1 2025 and to submit the findings to the U.S ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Survivors of blood or marrow transplants (BMT) face a significantly higher risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and ...